Seer inc.

Get the latest Seer Inc (SEER) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Seer inc. Things To Know About Seer inc.

Nov 7, 2023 · Seer Inc (NASDAQ:SEER) reported a gross profit of $2.2 million with a gross margin of 52% for the third quarter of 2023. Operating expenses saw a slight uptick to $28.0 million, a 4% increase from ... Throughout pharmaceutical development and academic/clinical research, Olink provides actionable insights through protein biomarkers across an extensive range of application areas, covering all aspects of human biology in health and disease. See all applications.Kogan led the legal and government affairs functions of Avanir Pharmaceuticals, Inc., a publicly traded pharmaceutical company, from May 2011 to August 2015, until its acquisition by Otsuka Pharmaceutical Co. Ltd. Prior roles included positions of increasing responsibility at King Pharmaceuticals, Inc., Bristol-Myers Squibb, and Bergen Brunswig ...THE FINANCE SEER LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, ...Realtime driving directions to Seer Inc., 3800 Bridge Pkwy, Redwood City, based on live traffic updates and road conditions – from Waze fellow drivers.

REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the ...Seer, Inc. operates as a biotechnology company. The Company offers solutions which combines proprietary engineered nanoparticles with an automated assay solution to provide an unmatched ...

C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 (Street) REDWOOD CITY: CA: 94065 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Seer, Inc. [ SEER] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below)Seer, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $4.6 million for the quarter ended December 2022, missing the Zacks Consensus Estimate by 0.69%.

SEER is a trusted provider of environmental services to a wide range of customers in a variety of business segments. Customer satisfaction is our hallmark and long-standing customer relationships are a testament to our commitment to understanding our customers’ needs and delivering our solutions in a timely, cost effective manner. This article is cited by 22 publications. Rongyuan Zhang, Zhenyu Bi, Liping Zhang, Han Yang, Haoran Wang, Weijie Zhang, Zijie Qiu, Chaoji Zhang, Yu Xiong, Yuanyuan Li, Zheng Zhao, Ben Zhong Tang. Blood Circulation Assessment by Steadily Fluorescent Near-Infrared-II Aggregation-Induced Emission Nano Contrast Agents.CompBio Workshop ICML 2022. July 22nd, 8:30AM-5:00PM EST, Friday,2022. Room 310, The Baltimore Convention Center, Baltimore, Maryland, USA. Machine learning advances are used in self-driving cars, speech recognition systems, and translation software. However, the COVID-19 pandemic has highlighted the urgency of translating such …Jan 5, 2021 · On behalf of our client, Seer, Inc. (the “Company”), we submit this letter in response to a comment from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) contained in its letter dated November 9, 2020 (the “Comment Letter”), relating to the above referenced Amendment No. 1 to Draft …

Jan 24, 2022 · What is Seer, Inc. (SEER)'s stock price history? Over the last year, Seer, Inc.’s stock price has decreased by 73.70%. Seer, Inc. is currently approximately $1.64 per share.

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company’s initial product, the Proteograph Product ...

3. Date of Earliest Transaction (Month/Day/Year) 01/17/2023: 4. If Amendment, Date of Original Filed (Month/Day/Year) 01/19/2023Seer, Inc. (SEER.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Seer, Inc. | Nasdaq: SEER | Nasdaq.Nov 27, 2023 · The average one-year price target for Seer Inc - (NASDAQ:SEER) has been revised to 10.20 / share. This is an increase of 33.33% from the prior estimate of 7.65 dated October 31, 2023. Discover Seer: Elevate Your Activewear Experience. Embrace self-expression and empowerment with our 2023-born global activewear brand.Seer, Inc. (NASDAQ:NASDAQ:SEER) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ETCompany ParticipantsCarrie Mendivil - Investor RelationsOmid...Feb 26, 2021 · seer seer inc . initial public offering additions russell 3000® index [february 26, 2021] 2 sgfy signify health inc sgtx sigilon therapeutics inc shc sotera health shls shoals technologies group inc snse sensei biotherapeutics inc tern terns pharmaceuticals inc tlis talis biomedical corpStrategic Environmental & Energy Resources, Inc. (SEER) is a publicly traded holding company that provides a wide range of environmental, renewable fuels ...

Proteomics analysis just got easier. Quickly and accurately analyze your data, investigate complex biology, and discover new biomarkers with Seer’s powerful, easy-to-use Proteograph™ Analysis Suite. Realtime driving directions to Seer Inc., 3800 Bridge Pkwy, Redwood City, based on live traffic updates and road conditions – from Waze fellow drivers.Nov 7, 2023 · --Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2023.. Achieved revenue ... Seer Inc. Cl A. 3800 Bridge Parkway. Suite 102. Redwood City, California 94065. Phone 1 650 453-0000. Industry Medical Equipment/Supplies. Sector Health Care/Life Sciences. REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report ...Seer, Inc. (SEER) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.32 per share a year ago. These figures are ...Nov 8, 2023 · Seer, Inc. (NASDAQ:NASDAQ:SEER) Q3 2023 Results Conference Call November 7, 2023 4:30 PM ETCompany ParticipantsCarrie Mendivil - IROmid Farokhzad -...

We are pleased to invite you to attend the 2023 Annual Meeting of Stockholders (the Annual Meeting) of Seer, Inc. (Seer or the Company), which will take place on Wednesday, June 14, 2023 at 1:00 p.m. Pacific Time. The Annual Meeting will …

REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. SEER, a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the ...Dec 18, 2020 · Seer, Inc. (Subject) CIK: 0001726445 (see all company filings) IRS No.: 821153150 | State of Incorp.:DE | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005 ...The Defence Ministry, in a statement, has said, “The Army, with support from the National Security Council Secretariat (NSCS), has recently established the Quantum …Apr 29, 2022 · Seer, Inc. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check the appropriate box): x: No fee required. o: Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2)Jan 5, 2021 · In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Seer, Inc. (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Time, on …Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across ... I have other questions and would like to speak with someone. (+1) 833-254-7337 (US only) Monday - Friday, 8am - 5pm PST. Seer, Inc. (SEER-1.63%) Q3 2021 Earnings Call Nov 09, 2021, 4:30 p.m. ET Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day. Thank you for ...Seer, Inc. UNAUDITED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share amounts) June 30, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 56,404 $ 53,208 Short-term investments 263,805 368,031 Accounts receivable, net 4,490 4,315 Related party receivablesSeer, Inc. (NASDAQ:NASDAQ:SEER) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ETCompany ParticipantsCarrie Mendivil – Investor RelationsOmid...

The average one-year price target for Seer Inc - (NASDAQ:SEER) has been revised to 10.20 / share. This is an increase of 33.33% from the prior estimate of 7.65 dated October 31, 2023.

Price Performance Review of SEER. On Friday, Seer Inc [NASDAQ:SEER] saw its stock jump 2.04% to $1.50. On the same session, the stock had its day’s lowest price of $1.47, but rose to a high of $1.535. Over the last five days, the stock has lost -3.85%. Seer Inc shares have fallen nearly -74.14% since the year began.

0001726445--12-312022Q3FalseP1Y00017264452022-01-012022-09-300001726445us-gaap:CommonClassAMember2022-11-04xbrli:shares0001726445us-gaap:CommonClassBMember2022-11 ...seer, inc. CONSULTANT AGREEMENT This Consultant Agreement (“Agreement”) is entered into as of September 30, 2022 (the “Effective Date”) between Seer, Inc., a Delaware corporation with its principal place of business at 3800 Bridge Parkway, Suite 102, Redwood City, CA 94065 (“Company”) and Omead Ostadan, an individual (“Consultant”).Seer | 7,681 followers on LinkedIn. Empowering scientists through unbiased, deep, rapid proteomics at scale | At Seer, we develop innovative solutions that act as a gateway to the proteome.Seer Technologies Inc. is a software consultancy, design, development and managed-services company focused on mobile, cloud and data technologies.Get the balance sheet for Seer Inc, which summarizes the company's financial position including assets, liabilities, and more.20 Years of Value Investing INR 0 Billion Assets Under Management Reporting Date: 31 Oct 2023 0 % 6 Year Annualized Return for SEP - Seers Enduring ...REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for …Director, Commercial Operations. Joined Seer August 2022. LinkedIn. Margaret Donovan. Our highly collaborative and high-energy environment has allowed Seer to become a leader in proteomics, and I'm excited to be a part of that journey. After joining Seer directly out of graduate school as a bioinformatician, I have been lucky to be supported by ...As pet owners, we want to keep our furry friends safe and secure. Invisible Fence Inc. has been providing pet owners with innovative solutions to keep their pets out of harm’s way for over 40 years. With their advanced technology, Invisible...

We are pleased to invite you to attend the 2023 Annual Meeting of Stockholders (the Annual Meeting) of Seer, Inc. (Seer or the Company), which will take place on Wednesday, June 14, 2023 at 1:00 p.m. Pacific Time. The Annual Meeting will …Proteomics analysis just got easier. Quickly and accurately analyze your data, investigate complex biology, and discover new biomarkers with Seer’s powerful, easy-to-use …In this episode of omg OMx, Bruker's science-driven podcast, Kate Stumpo interviews Daniel Hornburg, the VP of Proteomics at Seer, as they discuss the innovative technologies in plasma proteomics. From nanoparticle-based enrichment to mass spec refinements, they explore how these tools facilitate unbiased, deep, and rapid proteomics.Instagram:https://instagram. iphone 14 pro sold outchatgpt stock predictionsstock portfolio tracker appbrokerage account europe Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and ... silver dollar 1979 worthenergy transfer partners stock Seer Technologies, Inc. | 372 followers on LinkedIn. We are a software consultancy, design, development and managed-services company focused on mobile, cloud and data technologies. In over 11 ... jpm dividend date Earlier today, Seer released financial results for the quarter and year ended December 31, 2022. If you have not received this news release or if you'd like to be added to the company's ...Product and Service Revenue: Seer’s product revenue for the quarter reached $1.8 million, reflecting a 31% decline from $2.6 million in the third quarter of 2022. On the other hand, the company experienced an impressive growth in service revenue, which soared nearly eightfold from $68,000 in the same period last year to $536,000 in Q3 2023.